The U.S. FDA approved a pill version of the weight-loss injection 'Wegovy', which is likely to be launched in January 2026. During its clinical trials, close to 1300 participants experienced an average weight loss of 16.6% after 64 weeks. Meanwhile, Orforglipron- an oral pill manufactured by U.S. drugmaker Eli Lilly is awaiting regulatory clearance.


US drug regulator approves first-of-its-kind anti-obesity pill 'Wegovy'

weight-loss-pills

Weight Loss Pills, News on Weight Loss Pills, stories on Weight Loss Pills, articles on Weight Loss Pills, Weight Loss Pills stories at Wion, Weight Loss Pills news, Weight Loss Pills latest news

weight loss-pills

US drug regulator approves first-of-its-kind anti-obesity pill 'Wegovy'